BioRestorative Therapies BRTX
NASDAQ BRTX
$1.57 +0.02 (+1.29%)
As of: Nov 11, 2026 · 3:59 PM EST

BioRestorative Therapies (BRTX) Share-based Compensation (2010 - 2026)

Updated

BioRestorative Therapies' Share-based Compensation was $290,215 in Q1 2026, down 85.6% from $2.01 million a year earlier and down 35.2% from the prior quarter.

Analysis

BioRestorative Therapies (BRTX) Share-based Compensation (2010 - 2026) Analysis & Trends

On a trailing twelve-month basis, BioRestorative Therapies' Share-based Compensation was $1.61 million through Mar 31, 2026, down 42.5% year-over-year; for FY2025, it came in at $3.33 million, up 18.2% from FY2024.

  • Share-based Compensation shows a five-year compound annual growth rate of 36.9% (FY2020 to FY2025).
  • In earlier years, Share-based Compensation was $2.81 million in FY2024 (-63.9%), $7.78 million in FY2023 (-38.3%), $12.61 million in FY2022 (-45.4%) and $23.11 million in FY2021.
  • The Q1 2026 figure marks the lowest quarterly Share-based Compensation since Q4 2024.
  • Compared with a year earlier, Share-based Compensation was higher in three of the last eight quarters, with an average decline of 11.7%.
  • The best year-over-year quarter for Share-based Compensation over five years was Q2 2021 (growth of 703.7%); the worst was Q4 2024 (a decline of 88.0%).
  • Per Business Quant data, BRTX's Share-based Compensation in the three quarters before Q1 2026 was $447,860 (Q4 2025), $399,932 (Q3 2025) and $468,708 (Q2 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Stock Comp. (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 200.00 Mn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 357.00 Mn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 160.00 Mn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 369.00 Mn
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn -
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 128.00 Mn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 234.00 Mn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 362.00 Mn
10 BioRestorative Therapies 1.36 Mn -17.06 Mn 15,785.00 290,215.00
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 290,215.00
Dec 31, 2025 447,860.00
Sep 30, 2025 399,932.00
Jun 30, 2025 468,708.00
Mar 31, 2025 2.01 Mn
Dec 31, 2024 175,625.00
Sep 30, 2024 284,245.00
Jun 30, 2024 324,322.00
Mar 31, 2024 2.03 Mn
Dec 31, 2023 1.46 Mn
Sep 30, 2023 1.49 Mn
Jun 30, 2023 1.49 Mn
Mar 31, 2023 3.38 Mn
Dec 31, 2022 3.06 Mn
Sep 30, 2022 3.07 Mn
Jun 30, 2022 3.10 Mn
Mar 31, 2022 3.38 Mn
Dec 31, 2021 3.21 Mn
Sep 30, 2021 2.90 Mn
Jun 30, 2021 1.76 Mn
API Access

BioRestorative Therapies Share-based Compensation API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=share-based-compensation&ticker=BRTX&period=max&api_key=YOUR_API_KEY